Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

被引：0
|
作者：
Constant V. M. Verschuur
S. R. Suwijn
B. Post
M. Dijkgraaf
B. R. Bloem
J. J. van Hilten
T. van Laar
G. Tissingh
G. Deuschl
A. E. Lang
R. J. de Haan
R. M. A. de Bie
机构：
[1] University of Amsterdam,Department of Neurology, Academic Medical Center
[2] Radboud University Medical Center,Department of Neurology, Donders Institute for Brain, Cognition and Behavior
[3] Clinical Research Unit,Academic Medical Center
[4] Leiden University Medical Center,Department of Neurology
[5] University Medical Center Groningen,Department of Neurology
[6] Atrium-Orbis Medical Center Heerlen/Sittard,Department of Neurology
[7] University Medical Center Schleswig-Holstein,Department of Neurology
[8] University of Toronto,The Edmond J. Safra Program in Parkinson’s Disease and Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital
来源：
BMC Neurology | / 15卷
关键词：
Parkinson’s disease; Levodopa; Randomised delayed-start placebo-controlled trial; Disease modifying;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
    Damier, Philippe
    Degos, Bertrand
    Castelonovo, Giovanni
    Anheim, Mathieu
    Benatru, Isabelle
    Carriere, Nicolas
    Colin, Olivier
    Defebvre, Luc
    Deverdal, Marie
    Eusebio, Alexandre
    Ferrier, Vanessa
    Giordana, Caroline
    Houeto, Jean-Luc
    Le Dily, Severine
    Mongin, Marie
    Thiriez, Claire
    Tranchant, Christine
    Ravel, Denis
    Corvol, Jean-Christophe
    Rascol, Olivier
    Ben Ari, Yehezkel
    MOVEMENT DISORDERS, 2024, 39 (03) : 618 - 622
  • [22] Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial
    Brinke, Timo R. ten
    Jergas, Hannah
    Sisodia, Vibuthi
    Barbe, Michael T.
    Odekerken, Vincent J. J.
    Verbaan, Dagmar
    Dijk, Joke M.
    Bot, Maarten
    Beudel, Martijn
    van den Munckhof, Pepijn
    Schuurman, P. Rick
    de Bie, Rob M. A.
    BMC NEUROLOGY, 2023, 23 (01)
  • [23] Efficacy and safety of rasagiline as an adjunct to levodopa treatment in Chinese patients with Parkinson's disease: a randomized, double-blind, parallel-controlled, multi-centre trial
    Zhang, Lina
    Zhang, Zhiqin
    Chen, Yangmei
    Qin, Xinyue
    Zhou, Huadong
    Zhang, Chaodong
    Sun, Hongbin
    Tang, Ronghua
    Zheng, Jinou
    Yi, Lin
    Deng, Liying
    Li, Jinfang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (07) : 1529 - 1537
  • [24] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [25] Opicapone OCEAN study in Parkinson's: design of a randomized double-blind placebo-controlled trial
    Chaudhuri, K. Ray
    Odin, P.
    Ferreira, J.
    Antonini, A.
    Rascol, O.
    Kurtis, M.
    Storch, A.
    Bannister, K.
    Costa, R.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 902 - 902
  • [26] A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease
    Wermuth, L
    EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (03) : 235 - 242
  • [27] Dexmedetomidine after deep brain stimulation for prevention of delirium in elderly patients with Parkinson's disease: protocol for a single-centre, randomised, double-blind, placebo-controlled trial in China
    Yao, Jingxin
    Shen, Zhongyuan
    Jin, Hailong
    Ma, Tingting
    Wang, Jie
    Li, Shu
    Zeng, Min
    Liu, Xiaoyuan
    Peng, Yuming
    BMJ OPEN, 2023, 13 (07):
  • [28] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [29] Pingchan granule for depressive symptoms in parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Gu, Si-chun
    Zhou, Jie
    Ye, Qing
    Yuan, Can-xing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 120 - 128
  • [30] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
12345